Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Wu

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Neoplasia (New York, N.Y.)|February 28, 2021
High dose acetaminophen inhibits STAT3 and has free radical independent anti-cancer stem cell activityPavani Pingali, Y Jeffrey Wu, Rio Boothello, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2018
A Prospective Phase 2 Study Evaluating Safety and Efficacy of Combining Stereotactic Body Radiation Therapy With Heat-based Ablation for Centrally Located Lung TumorsKiri A Sandler, Fereidoun Abtin, Robert Suh, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 2008
Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptaseZachary K Sweeney, Sahaja Acharya, Andrew Briggs, et al.
Proceedings (Baylor University. Medical Center)|December 29, 2022
The Texas Immuno-Oncology Biorepository, a statewide biospecimen collection and clinical informatics system to enable longitudinal tumor and immune profilingRonan J Kelly, Timothy G Whitsett, G Jackson Snipes, et al.
Chemmedchem|November 14, 2008
Diphenyl ether non-nucleoside reverse transcriptase inhibitors with excellent potency against resistant mutant viruses and promising pharmacokinetic propertiesZachary K Sweeney, Joshua J Kennedy-Smith, Jeffrey Wu, et al.
Journal of Medicinal Chemistry|November 15, 2008
Design of annulated pyrazoles as inhibitors of HIV-1 reverse transcriptaseZachary K Sweeney, Seth F Harris, Seth F Arora, et al.
Journal of Medicinal Chemistry|February 1, 2024
Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton's Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell MalignanciesDaniel W Robbins, Mark A Noviski, Ying Siow Tan, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Neoplasia (New York, N.Y.)|February 28, 2021
High dose acetaminophen inhibits STAT3 and has free radical independent anti-cancer stem cell activityPavani Pingali, Y Jeffrey Wu, Rio Boothello, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2018
A Prospective Phase 2 Study Evaluating Safety and Efficacy of Combining Stereotactic Body Radiation Therapy With Heat-based Ablation for Centrally Located Lung TumorsKiri A Sandler, Fereidoun Abtin, Robert Suh, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 2008
Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptaseZachary K Sweeney, Sahaja Acharya, Andrew Briggs, et al.
Proceedings (Baylor University. Medical Center)|December 29, 2022
The Texas Immuno-Oncology Biorepository, a statewide biospecimen collection and clinical informatics system to enable longitudinal tumor and immune profilingRonan J Kelly, Timothy G Whitsett, G Jackson Snipes, et al.
Chemmedchem|November 14, 2008
Diphenyl ether non-nucleoside reverse transcriptase inhibitors with excellent potency against resistant mutant viruses and promising pharmacokinetic propertiesZachary K Sweeney, Joshua J Kennedy-Smith, Jeffrey Wu, et al.
Journal of Medicinal Chemistry|November 15, 2008
Design of annulated pyrazoles as inhibitors of HIV-1 reverse transcriptaseZachary K Sweeney, Seth F Harris, Seth F Arora, et al.
Journal of Medicinal Chemistry|February 1, 2024
Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton's Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell MalignanciesDaniel W Robbins, Mark A Noviski, Ying Siow Tan, et al.
Pageof 5